0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Early Diagnosis Kit For Alzheimer's Disease Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-35D10378
Home | Market Reports | Health| Aging & Geriatrics
Global Early Diagnosis Kit For Alzheimer s Disease Market Research Report 2022
BUY CHAPTERS

Global Early Diagnosis Kit For Alzheimer's Disease Market Research Report 2025

Code: QYRE-Auto-35D10378
Report
April 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Early Diagnosis Kit For Alzheimer's Disease Market Size

The global market for Early Diagnosis Kit For Alzheimer's Disease was valued at US$ 125 million in the year 2024 and is projected to reach a revised size of US$ 216 million by 2031, growing at a CAGR of 8.3% during the forecast period.

Early Diagnosis Kit For Alzheimer's Disease Market

Early Diagnosis Kit For Alzheimer's Disease Market

Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects the brain, leading to cognitive decline and memory loss. It is the most common cause of dementia, a syndrome characterized by a decline in cognitive function that interferes with daily life. Alzheimer's disease is named after Dr. Alois Alzheimer, who first identified the condition in 1906. Currently, there is not significant leading product on the market, and the competition landscape for AD diagnostic reagents is relatively good. In the future, with the approval of more accurate mass spectrometry and other kits, the application of combined detection methods, and the approval of more AD treatment drugs, the AD diagnostic industry has huge development potential, and the market space may further expand. The cerebrospinal fluid (CSF) biomarkers, that were first developed by Fujirebio more than 25 years ago, have evolved over time from research biomarkers into specialized diagnostic testing tools, and from manual usage by early adopters to a widespread implementation in fully automated routine testing today. Diagnosis for Alzheimer's disease using CSF samples allows the detection of four proteins: two forms of amyloid (Aβ1-42 and Aβ1-40) proteins and two forms of Tau (Total Tau and phospho-Tau) proteins. If a patient has Alzheimer's disease, then these proteins will be present in abnormally low (Aβ1-42 and Aβ1-42/Aβ1-40 ratio) and high (Total Tau and phospho-Tau) levels. The Aβ1-42 levels and the Aβ1-42/Aβ1-40 ratio will even be low long before the symptoms of the disease start to show. In the clinical community today, there are high hopes for the use of blood-based testing for even simpler and potentially more widespread testing for Alzheimer's disease in clinical routine.
Global 3 key players of Carbonized Rice Husk are Roche Diagnostics, Fujirebio and Quanterix, with about 52% market shares. Asia-Pacific is the largest market, which has a share about 38%, followed by Europe and North America, with share 29% and 27%, separately. In terms of product type, CSF is the largest segment, occupied for a share of 59%. And in terms of application, medical is the largest, with a share about 75 percent.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Early Diagnosis Kit For Alzheimer's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Early Diagnosis Kit For Alzheimer's Disease.
The Early Diagnosis Kit For Alzheimer's Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Early Diagnosis Kit For Alzheimer's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Early Diagnosis Kit For Alzheimer's Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Early Diagnosis Kit For Alzheimer's Disease Market Report

Report Metric Details
Report Name Early Diagnosis Kit For Alzheimer's Disease Market
Accounted market size in year US$ 125 million
Forecasted market size in 2031 US$ 216 million
CAGR 8.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Blood
  • CSF
  • Others
Segment by Application
  • Medical
  • Research
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Fujirebio, Quanterix, Roche Diagnostics, Revvity, People Bio, Easund Bio-tech and Pharmakea, MagQu, Solgent, Sysmex, Fujifilm, Immuno-Biological Laboratories, Shenzhen Anqun Bioengineering, Amoneta Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Early Diagnosis Kit For Alzheimer's Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Early Diagnosis Kit For Alzheimer's Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Early Diagnosis Kit For Alzheimer's Disease Market growing?

Ans: The Early Diagnosis Kit For Alzheimer's Disease Market witnessing a CAGR of 8.3% during the forecast period 2025-2031.

What is the Early Diagnosis Kit For Alzheimer's Disease Market size in 2031?

Ans: The Early Diagnosis Kit For Alzheimer's Disease Market size in 2031 will be US$ 216 million.

What is the Roche Diagnostics, Fujirebio, Quanterix share in Early Diagnosis Kit For Alzheimer's Disease Market?

Ans: Global 3 key players of Carbonized Rice Husk are Roche Diagnostics, Fujirebio and Quanterix, with about 52% market shares.

What is the Early Diagnosis Kit For Alzheimer's Disease Market share by region?

Ans: Asia-Pacific is the largest market, which has a share about 38%, followed by Europe and North America, with share 29% and 27%, separately.

What is the Early Diagnosis Kit For Alzheimer's Disease Market share by type?

Ans: In terms of product type, CSF is the largest segment, occupied for a share of 59%.

Who are the main players in the Early Diagnosis Kit For Alzheimer's Disease Market report?

Ans: The main players in the Early Diagnosis Kit For Alzheimer's Disease Market are Fujirebio, Quanterix, Roche Diagnostics, Revvity, People Bio, Easund Bio-tech and Pharmakea, MagQu, Solgent, Sysmex, Fujifilm, Immuno-Biological Laboratories, Shenzhen Anqun Bioengineering, Amoneta Diagnostics

What are the Application segmentation covered in the Early Diagnosis Kit For Alzheimer's Disease Market report?

Ans: The Applications covered in the Early Diagnosis Kit For Alzheimer's Disease Market report are Medical, Research

What are the Type segmentation covered in the Early Diagnosis Kit For Alzheimer's Disease Market report?

Ans: The Types covered in the Early Diagnosis Kit For Alzheimer's Disease Market report are Blood, CSF, Others

1 Early Diagnosis Kit For Alzheimer's Disease Market Overview
1.1 Product Definition
1.2 Early Diagnosis Kit For Alzheimer's Disease by Type
1.2.1 Global Early Diagnosis Kit For Alzheimer's Disease Market Value Comparison by Type (2024 VS 2031)
1.2.2 Blood
1.2.3 CSF
1.2.4 Others
1.3 Early Diagnosis Kit For Alzheimer's Disease by Application
1.3.1 Global Early Diagnosis Kit For Alzheimer's Disease Market Value by Application (2024 VS 2031)
1.3.2 Medical
1.3.3 Research
1.4 Global Early Diagnosis Kit For Alzheimer's Disease Market Size Estimates and Forecasts
1.4.1 Global Early Diagnosis Kit For Alzheimer's Disease Revenue 2020-2031
1.4.2 Global Early Diagnosis Kit For Alzheimer's Disease Sales 2020-2031
1.4.3 Global Early Diagnosis Kit For Alzheimer's Disease Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Early Diagnosis Kit For Alzheimer's Disease Market Competition by Manufacturers
2.1 Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Manufacturers (2020-2025)
2.2 Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Early Diagnosis Kit For Alzheimer's Disease Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Early Diagnosis Kit For Alzheimer's Disease, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Early Diagnosis Kit For Alzheimer's Disease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Early Diagnosis Kit For Alzheimer's Disease, Product Type & Application
2.7 Global Key Manufacturers of Early Diagnosis Kit For Alzheimer's Disease, Date of Enter into This Industry
2.8 Global Early Diagnosis Kit For Alzheimer's Disease Market Competitive Situation and Trends
2.8.1 Global Early Diagnosis Kit For Alzheimer's Disease Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Early Diagnosis Kit For Alzheimer's Disease Players Market Share by Revenue
2.8.3 Global Early Diagnosis Kit For Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Early Diagnosis Kit For Alzheimer's Disease Market Scenario by Region
3.1 Global Early Diagnosis Kit For Alzheimer's Disease Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Early Diagnosis Kit For Alzheimer's Disease Sales by Region: 2020-2031
3.2.1 Global Early Diagnosis Kit For Alzheimer's Disease Sales by Region: 2020-2025
3.2.2 Global Early Diagnosis Kit For Alzheimer's Disease Sales by Region: 2026-2031
3.3 Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Region: 2020-2031
3.3.1 Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Region: 2020-2025
3.3.2 Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Region: 2026-2031
3.4 North America Early Diagnosis Kit For Alzheimer's Disease Market Facts & Figures by Country
3.4.1 North America Early Diagnosis Kit For Alzheimer's Disease Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2020-2031)
3.4.3 North America Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Early Diagnosis Kit For Alzheimer's Disease Market Facts & Figures by Country
3.5.1 Europe Early Diagnosis Kit For Alzheimer's Disease Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2020-2031)
3.5.3 Europe Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Market Facts & Figures by Region
3.6.1 Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Sales by Region (2020-2031)
3.6.3 Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Early Diagnosis Kit For Alzheimer's Disease Market Facts & Figures by Country
3.7.1 Latin America Early Diagnosis Kit For Alzheimer's Disease Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2020-2031)
3.7.3 Latin America Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Market Facts & Figures by Country
3.8.1 Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2020-2031)
3.8.3 Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2020-2031)
4.1.1 Global Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2020-2025)
4.1.2 Global Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2026-2031)
4.1.3 Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Type (2020-2031)
4.2 Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Type (2020-2031)
4.2.1 Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Type (2020-2025)
4.2.2 Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Type (2026-2031)
4.2.3 Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Type (2020-2031)
4.3 Global Early Diagnosis Kit For Alzheimer's Disease Price by Type (2020-2031)
5 Segment by Application
5.1 Global Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2020-2031)
5.1.1 Global Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2020-2025)
5.1.2 Global Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2026-2031)
5.1.3 Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Application (2020-2031)
5.2 Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Application (2020-2031)
5.2.1 Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Application (2020-2025)
5.2.2 Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Application (2026-2031)
5.2.3 Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Application (2020-2031)
5.3 Global Early Diagnosis Kit For Alzheimer's Disease Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Fujirebio
6.1.1 Fujirebio Company Information
6.1.2 Fujirebio Description and Business Overview
6.1.3 Fujirebio Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Fujirebio Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.1.5 Fujirebio Recent Developments/Updates
6.2 Quanterix
6.2.1 Quanterix Company Information
6.2.2 Quanterix Description and Business Overview
6.2.3 Quanterix Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Quanterix Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.2.5 Quanterix Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Company Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Diagnostics Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 Revvity
6.4.1 Revvity Company Information
6.4.2 Revvity Description and Business Overview
6.4.3 Revvity Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Revvity Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.4.5 Revvity Recent Developments/Updates
6.5 People Bio
6.5.1 People Bio Company Information
6.5.2 People Bio Description and Business Overview
6.5.3 People Bio Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.5.4 People Bio Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.5.5 People Bio Recent Developments/Updates
6.6 Easund Bio-tech and Pharmakea
6.6.1 Easund Bio-tech and Pharmakea Company Information
6.6.2 Easund Bio-tech and Pharmakea Description and Business Overview
6.6.3 Easund Bio-tech and Pharmakea Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Easund Bio-tech and Pharmakea Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.6.5 Easund Bio-tech and Pharmakea Recent Developments/Updates
6.7 MagQu
6.7.1 MagQu Company Information
6.7.2 MagQu Description and Business Overview
6.7.3 MagQu Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MagQu Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.7.5 MagQu Recent Developments/Updates
6.8 Solgent
6.8.1 Solgent Company Information
6.8.2 Solgent Description and Business Overview
6.8.3 Solgent Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Solgent Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.8.5 Solgent Recent Developments/Updates
6.9 Sysmex
6.9.1 Sysmex Company Information
6.9.2 Sysmex Description and Business Overview
6.9.3 Sysmex Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sysmex Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.9.5 Sysmex Recent Developments/Updates
6.10 Fujifilm
6.10.1 Fujifilm Company Information
6.10.2 Fujifilm Description and Business Overview
6.10.3 Fujifilm Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Fujifilm Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.10.5 Fujifilm Recent Developments/Updates
6.11 Immuno-Biological Laboratories
6.11.1 Immuno-Biological Laboratories Company Information
6.11.2 Immuno-Biological Laboratories Description and Business Overview
6.11.3 Immuno-Biological Laboratories Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Immuno-Biological Laboratories Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.11.5 Immuno-Biological Laboratories Recent Developments/Updates
6.12 Shenzhen Anqun Bioengineering
6.12.1 Shenzhen Anqun Bioengineering Company Information
6.12.2 Shenzhen Anqun Bioengineering Description and Business Overview
6.12.3 Shenzhen Anqun Bioengineering Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shenzhen Anqun Bioengineering Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.12.5 Shenzhen Anqun Bioengineering Recent Developments/Updates
6.13 Amoneta Diagnostics
6.13.1 Amoneta Diagnostics Company Information
6.13.2 Amoneta Diagnostics Description and Business Overview
6.13.3 Amoneta Diagnostics Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Amoneta Diagnostics Early Diagnosis Kit For Alzheimer's Disease Product Portfolio
6.13.5 Amoneta Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Early Diagnosis Kit For Alzheimer's Disease Industry Chain Analysis
7.2 Early Diagnosis Kit For Alzheimer's Disease Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Early Diagnosis Kit For Alzheimer's Disease Production Mode & Process Analysis
7.4 Early Diagnosis Kit For Alzheimer's Disease Sales and Marketing
7.4.1 Early Diagnosis Kit For Alzheimer's Disease Sales Channels
7.4.2 Early Diagnosis Kit For Alzheimer's Disease Distributors
7.5 Early Diagnosis Kit For Alzheimer's Disease Customer Analysis
8 Early Diagnosis Kit For Alzheimer's Disease Market Dynamics
8.1 Early Diagnosis Kit For Alzheimer's Disease Industry Trends
8.2 Early Diagnosis Kit For Alzheimer's Disease Market Drivers
8.3 Early Diagnosis Kit For Alzheimer's Disease Market Challenges
8.4 Early Diagnosis Kit For Alzheimer's Disease Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Early Diagnosis Kit For Alzheimer's Disease Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Early Diagnosis Kit For Alzheimer's Disease Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Early Diagnosis Kit For Alzheimer's Disease Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Early Diagnosis Kit For Alzheimer's Disease Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Early Diagnosis Kit For Alzheimer's Disease Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Early Diagnosis Kit For Alzheimer's Disease Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Early Diagnosis Kit For Alzheimer's Disease, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Early Diagnosis Kit For Alzheimer's Disease, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Early Diagnosis Kit For Alzheimer's Disease, Product Type & Application
 Table 12. Global Key Manufacturers of Early Diagnosis Kit For Alzheimer's Disease, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Early Diagnosis Kit For Alzheimer's Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Early Diagnosis Kit For Alzheimer's Disease as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Early Diagnosis Kit For Alzheimer's Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Early Diagnosis Kit For Alzheimer's Disease Sales by Region (2020-2025) & (K Units)
 Table 18. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Region (2020-2025)
 Table 19. Global Early Diagnosis Kit For Alzheimer's Disease Sales by Region (2026-2031) & (K Units)
 Table 20. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Region (2026-2031)
 Table 21. Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Region (2020-2025)
 Table 23. Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Region (2026-2031)
 Table 25. North America Early Diagnosis Kit For Alzheimer's Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2020-2025) & (K Units)
 Table 27. North America Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2026-2031) & (K Units)
 Table 28. North America Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Early Diagnosis Kit For Alzheimer's Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Early Diagnosis Kit For Alzheimer's Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Early Diagnosis Kit For Alzheimer's Disease Sales (K Units) by Type (2020-2025)
 Table 51. Global Early Diagnosis Kit For Alzheimer's Disease Sales (K Units) by Type (2026-2031)
 Table 52. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Type (2020-2025)
 Table 53. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Type (2026-2031)
 Table 54. Global Early Diagnosis Kit For Alzheimer's Disease Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Early Diagnosis Kit For Alzheimer's Disease Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Type (2020-2025)
 Table 57. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Type (2026-2031)
 Table 58. Global Early Diagnosis Kit For Alzheimer's Disease Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Early Diagnosis Kit For Alzheimer's Disease Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Early Diagnosis Kit For Alzheimer's Disease Sales (K Units) by Application (2020-2025)
 Table 61. Global Early Diagnosis Kit For Alzheimer's Disease Sales (K Units) by Application (2026-2031)
 Table 62. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Application (2020-2025)
 Table 63. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Application (2026-2031)
 Table 64. Global Early Diagnosis Kit For Alzheimer's Disease Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Early Diagnosis Kit For Alzheimer's Disease Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Application (2020-2025)
 Table 67. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Application (2026-2031)
 Table 68. Global Early Diagnosis Kit For Alzheimer's Disease Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Early Diagnosis Kit For Alzheimer's Disease Price (US$/Unit) by Application (2026-2031)
 Table 70. Fujirebio Company Information
 Table 71. Fujirebio Description and Business Overview
 Table 72. Fujirebio Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Fujirebio Early Diagnosis Kit For Alzheimer's Disease Product
 Table 74. Fujirebio Recent Developments/Updates
 Table 75. Quanterix Company Information
 Table 76. Quanterix Description and Business Overview
 Table 77. Quanterix Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Quanterix Early Diagnosis Kit For Alzheimer's Disease Product
 Table 79. Quanterix Recent Developments/Updates
 Table 80. Roche Diagnostics Company Information
 Table 81. Roche Diagnostics Description and Business Overview
 Table 82. Roche Diagnostics Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Roche Diagnostics Early Diagnosis Kit For Alzheimer's Disease Product
 Table 84. Roche Diagnostics Recent Developments/Updates
 Table 85. Revvity Company Information
 Table 86. Revvity Description and Business Overview
 Table 87. Revvity Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Revvity Early Diagnosis Kit For Alzheimer's Disease Product
 Table 89. Revvity Recent Developments/Updates
 Table 90. People Bio Company Information
 Table 91. People Bio Description and Business Overview
 Table 92. People Bio Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. People Bio Early Diagnosis Kit For Alzheimer's Disease Product
 Table 94. People Bio Recent Developments/Updates
 Table 95. Easund Bio-tech and Pharmakea Company Information
 Table 96. Easund Bio-tech and Pharmakea Description and Business Overview
 Table 97. Easund Bio-tech and Pharmakea Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Easund Bio-tech and Pharmakea Early Diagnosis Kit For Alzheimer's Disease Product
 Table 99. Easund Bio-tech and Pharmakea Recent Developments/Updates
 Table 100. MagQu Company Information
 Table 101. MagQu Description and Business Overview
 Table 102. MagQu Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. MagQu Early Diagnosis Kit For Alzheimer's Disease Product
 Table 104. MagQu Recent Developments/Updates
 Table 105. Solgent Company Information
 Table 106. Solgent Description and Business Overview
 Table 107. Solgent Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Solgent Early Diagnosis Kit For Alzheimer's Disease Product
 Table 109. Solgent Recent Developments/Updates
 Table 110. Sysmex Company Information
 Table 111. Sysmex Description and Business Overview
 Table 112. Sysmex Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Sysmex Early Diagnosis Kit For Alzheimer's Disease Product
 Table 114. Sysmex Recent Developments/Updates
 Table 115. Fujifilm Company Information
 Table 116. Fujifilm Description and Business Overview
 Table 117. Fujifilm Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Fujifilm Early Diagnosis Kit For Alzheimer's Disease Product
 Table 119. Fujifilm Recent Developments/Updates
 Table 120. Immuno-Biological Laboratories Company Information
 Table 121. Immuno-Biological Laboratories Description and Business Overview
 Table 122. Immuno-Biological Laboratories Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Immuno-Biological Laboratories Early Diagnosis Kit For Alzheimer's Disease Product
 Table 124. Immuno-Biological Laboratories Recent Developments/Updates
 Table 125. Shenzhen Anqun Bioengineering Company Information
 Table 126. Shenzhen Anqun Bioengineering Description and Business Overview
 Table 127. Shenzhen Anqun Bioengineering Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Shenzhen Anqun Bioengineering Early Diagnosis Kit For Alzheimer's Disease Product
 Table 129. Shenzhen Anqun Bioengineering Recent Developments/Updates
 Table 130. Amoneta Diagnostics Company Information
 Table 131. Amoneta Diagnostics Description and Business Overview
 Table 132. Amoneta Diagnostics Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Amoneta Diagnostics Early Diagnosis Kit For Alzheimer's Disease Product
 Table 134. Amoneta Diagnostics Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Early Diagnosis Kit For Alzheimer's Disease Distributors List
 Table 138. Early Diagnosis Kit For Alzheimer's Disease Customers List
 Table 139. Early Diagnosis Kit For Alzheimer's Disease Market Trends
 Table 140. Early Diagnosis Kit For Alzheimer's Disease Market Drivers
 Table 141. Early Diagnosis Kit For Alzheimer's Disease Market Challenges
 Table 142. Early Diagnosis Kit For Alzheimer's Disease Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Early Diagnosis Kit For Alzheimer's Disease
 Figure 2. Global Early Diagnosis Kit For Alzheimer's Disease Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Early Diagnosis Kit For Alzheimer's Disease Market Share by Type: 2024 & 2031
 Figure 4. Blood Product Picture
 Figure 5. CSF Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Early Diagnosis Kit For Alzheimer's Disease Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Early Diagnosis Kit For Alzheimer's Disease Market Share by Application: 2024 & 2031
 Figure 9. Medical
 Figure 10. Research
 Figure 11. Global Early Diagnosis Kit For Alzheimer's Disease Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Early Diagnosis Kit For Alzheimer's Disease Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Early Diagnosis Kit For Alzheimer's Disease Sales (2020-2031) & (K Units)
 Figure 14. Global Early Diagnosis Kit For Alzheimer's Disease Average Price (US$/Unit) & (2020-2031)
 Figure 15. Early Diagnosis Kit For Alzheimer's Disease Report Years Considered
 Figure 16. Early Diagnosis Kit For Alzheimer's Disease Sales Share by Manufacturers in 2024
 Figure 17. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Early Diagnosis Kit For Alzheimer's Disease Players: Market Share by Revenue in Early Diagnosis Kit For Alzheimer's Disease in 2024
 Figure 19. Early Diagnosis Kit For Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Early Diagnosis Kit For Alzheimer's Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country (2020-2031)
 Figure 22. North America Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Country (2020-2031)
 Figure 23. United States Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country (2020-2031)
 Figure 26. Europe Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Region (2020-2031)
 Figure 34. China Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. U.A.E Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Early Diagnosis Kit For Alzheimer's Disease by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Early Diagnosis Kit For Alzheimer's Disease by Type (2020-2031)
 Figure 54. Global Early Diagnosis Kit For Alzheimer's Disease Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Early Diagnosis Kit For Alzheimer's Disease by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Early Diagnosis Kit For Alzheimer's Disease by Application (2020-2031)
 Figure 57. Global Early Diagnosis Kit For Alzheimer's Disease Price (US$/Unit) by Application (2020-2031)
 Figure 58. Early Diagnosis Kit For Alzheimer's Disease Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String